SUZ

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Acute PainPain

Phase 1

A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists

CompletedNCT06834009

Vertex Pharmaceuticals IncorporatedPain

Start: 2025-03-10End: 2025-04-24Updated: 2025-05-14

Phase 3

Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy

CompletedNCT05553366

Vertex Pharmaceuticals IncorporatedAcute Pain

Start: 2022-10-03End: 2023-12-15Updated: 2025-08-01

Related Papers

Suzetrigine, a Non-Opioid NaV1.8 Inhibitor for Treatment of Moderate-to-Severe Acute Pain: Two Phase 3 Randomized Clinical Trials

Anesthesiology2025-03-2128 citations